Aldeyra Therapeutics Stock Forecast

Stock Price Forecast

The 2 analysts that cover Aldeyra Therapeutics stock have a consensus rating of "Buy" and an average price target of $5.50, which forecasts a 257.14% increase in the stock price over the next year. The lowest target is $2.00 and the highest is $9.00.

Price Target: $5.50 (+257.14%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$2.00	$5.50	$9.00	$9.00
Change	+29.87%	+257.14%	+484.42%	+484.42%

* Price targets were last updated on Mar 18, 2026.

Analyst Ratings

The average analyst rating for Aldeyra Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Nov '25	Dec '25	Jan '26	Feb '26	Mar '26	Apr '26
Strong Buy	2	2	2	2	1	1
Buy	0	0	0	0	0	0
Hold	0	0	0	0	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy → Hold Downgrades $10 → $2	Strong Buy → Hold	Downgrades	$10 → $2	+29.87%	Mar 18, 2026
Thomas Shrader BTIG	BTIG	Strong Buy Reiterates $9	Strong Buy	Reiterates	$9	+484.42%	Nov 10, 2025
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+549.35%	May 19, 2025
Thomas Shrader BTIG	BTIG	Strong Buy Maintains $11 → $9	Strong Buy	Maintains	$11 → $9	+484.42%	Apr 7, 2025
Matthew Caufield HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $10	Strong Buy	Reiterates	$10	+549.35%	Apr 4, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

27.66M

Revenue Next Year

16.78M

from 27.66M

-39.34%

from 27.66M

EPS This Year

-0.47

from -0.56

EPS Next Year

-0.32

from -0.47

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	-	-	-	-	-	27.66M	16.78M
Revenue Growth	-	-	-	-	-	-	-39.34%
EPS	-1.07	-1.06	-0.64	-0.94	-0.56	-0.47	-0.32
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	8	7

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2026	2027
High	86.0M	38.2M
Avg	27.7M	16.8M
Low	n/a	n/a

Revenue Growth

Revenue Growth	2026	2027
High	-	38.0%
Avg	-	-39.3%
Low	-	-

EPS Forecast

EPS	2026	2027
High	-0.39	-0.25
Avg	-0.47	-0.32
Low	-0.63	-0.41

EPS Growth

EPS Growth	2026	2027
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.